November 18, 2014 - The Heart Rhythm Society convened a research symposium on December 9–10, 2013, in Washington, DC, that focused on the prevention of atrial fibrillation (AF) as well as AF-related stroke and morbidity.Attendees sought to summarize advances in understanding AF since a 2008 National Institutes of Health(NIH) conference on this topic and to identify continued knowledge gaps and current research priorities. This resultant whitepaper was developed in collaboration with and endorsed by the European Heart Rhythm Association (EHRA) and the Canadian Heart Rhythm Society (CHRS). It summarizes the deliberations of the attendees in an effort to accelerate progress toward preventing AF and its consequences.
Clinical Guidelines & Documents
Call for Public Comment on ICD Programming and Defibrillation Testing Recommendations
The 2015 HRS/EHRA/APHRS/SOLAECE Expert Consensus Statement on ICD Programming and Defibrillation Testing recommendations are now available for a 30 day public comment period.
The expert consensus statement is an international initiative to provide best practice recommendations on optimal programming for primary and secondary prevention ICDs, inappropriate shock avoidance programming (detection times, SVT discrimination, ATP), and use of defibrillation testing, including indications at time of implant or follow-up and testing protocols. The recommendations are in four main categories: bradycardia, tachycardia detection, tachycardia therapy, and defibrillation testing
The draft recommendations were developed by a writing group of 37 experts representing 19 countries, from the following organizations: Heart Rhythm Society (HRS), The European Heart Rhythm Association (EHRA), Asia-Pacific Heart Rhythm Society (APHRS), Latin American Society of Cardiac Pacing and Electrophysiology (SOLAECE) and in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA). The final approved document will be published in the fall of 2015.
This is a rare opportunity to view and comment on the recommendations prior to publication. Comments will be accepted from now until February 23, 2015. Use the ACC-AHA Class of Recommendation and Level of Evidence Table as a point of reference.
Please email email@example.com should you have questions or need further information.
Featured Clinical Documents
August 25, 2014 - This document on the Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions is a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS).
May 9, 2014 - This international expert consensus statement was written by experts in the field who were chosen by the Heart Rhythm Society in collaboration with representatives from the American College of Cardiology, American College of Chest Physicians, American Heart Association, Asia Pacific Heart Rhythm Society, European Hear Rhythm Association, and World Association for Sarcoidosis and Other Granulomatous Disorders (WASOG).
May 8, 2014 - This expert consensus statement was developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS) and endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD).